Activated iNKT cells have been demonstrated to be directly cytotoxic to CD1d-bearing tumor cells in a CD1d-dependent manner in vitro, and studies have directly correlated tumor expression of CD1d to their sensitivity to iNKT-mediated antitumor immunity in vivo[25],[26]. This evidence concerns the gene CD1D and neoplasm.